László Petri

HUN-REN Research Centre for Natural Sciences — Hungary

Chemistry · Physical Sciences

12h-index548citations31works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Click Chemistry and Applications(15), Chemical Synthesis and Analysis(14), Peptidase Inhibition and Analysis(8), Computational Drug Discovery Methods(5), Protein Degradation and Inhibitors(5)

Publications31 total

Ultrahigh-Throughput Virtual Screening Strategies against PPI Targets: A Case Study of STAT Inhibitors
Journal of Chemical Information and Modeling·2025· 3 citedOpen Access
Allosteric Covalent Inhibitors of the STAT3 Transcription Factor from Virtual Screening
ACS Medicinal Chemistry Letters·2025· 2 citedOpen Access
Size-Dependent Target Engagement of Covalent Probes
Journal of Medicinal Chemistry·2025· 4 citedOpen Access
Target Agnostic Photoaffinity Labelling by Sulfonylhydrazones
Angewandte Chemie International Edition·2025· 3 citedOpen Access
Target Agnostic Photoaffinity Labelling by Sulfonylhydrazones
Angewandte Chemie·2025Open Access
The PARP inhibitor rucaparib blocks SARS‐CoV‐2 virus binding to cells and the immune reaction in models of COVID‐19
British Journal of Pharmacology·2024· 7 citedOpen Access
Site-Selective Antibody Conjugation with Dibromopyrazines
Bioconjugate Chemistry·2024· 5 citedOpen Access
Mapping protein binding sites by photoreactive fragment pharmacophores
Communications Chemistry·2024· 7 citedOpen Access
Contribution of Noncovalent Recognition and Reactivity to the Optimization of Covalent Inhibitors: A Case Study on KRas<sup>G12C</sup>
ACS Chemical Biology·2024· 3 citedOpen Access
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors
Journal of Medicinal Chemistry·2023· 13 citedOpen Access
Mapping protein binding sites by photoreactive fragment pharmacophores
2023Open Access
Activation-Free Sulfonyl Fluoride Probes for Fragment Screening
Molecules·2023· 5 citedOpen Access
Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency
European Journal of Medicinal Chemistry·2023· 5 citedOpen Access
Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors
Pharmaceuticals·2022· 7 citedOpen Access
Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria
Scientific Reports·2022· 7 citedOpen Access
Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead
European Journal of Medicinal Chemistry·2022· 18 citedOpen Access
Rucaparib blocks SARS-CoV-2 virus binding to cells and interleukin-6 release in a model of COVID-19
2022· 1 citedOpen Access
A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors
European Journal of Medicinal Chemistry·2022· 19 citedOpen Access
Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads
Cells·2021· 8 citedOpen Access
Discovery of selective fragment-sized immunoproteasome inhibitors
European Journal of Medicinal Chemistry·2021· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

György M. Keserű(29), Péter Ábrányi‐Balogh(24), Tı́mea Imre(16), Dávid Bajusz(10), Nikolett Péczka(9), Stanislav Gobec(8), György G. Ferenczy(7), Aaron Keeley(7), Zoltán Orgován(7), József Tóvári(6), Martina Hrast(5), Damijan Knez(5), András Perczel(5), Gyula Pálfy(4), Tibor Viktor Szalai(4), Tamás Takács(4), Gitta Schlosser(4), Péter A. Szijj(3), Attila Egyed(3), Martina Gobec(3)